American Journal of Ophthalmology
Volume 146, Issue 3 , Pages 350-356.e1 , September 2008

Advances in Understanding and Managing Dry Eye Disease

  • Michael A. Lemp

      Affiliations

    • Corresponding Author InformationInquiries to Michael A. Lemp, 4000 Cathedral Avenue NW, No. 828B, Washington, DC 20016

,Accepted 14 May 2008.

References 

  1. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interactions between the ocular surface and the lacrimal glands. Cornea. 1998;17:584–589
  2. Holly FJ, Lemp MA. Tear physiology and dry eyes. Surv Ophthalmol. 1977;22:69–87
  3. Lemp MA. Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes. CLAO J. 1995;2:221–232
  4. Gipson IK, Hori I, Argueso P. Character of ocular surface mucins and their alterations in dry eye disease. Ocular Surf. 2004;2:131–148
  5. Lemp MA, Baudouin C, Baum J, et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocular Surf. 2007;5:75–92
  6. Stern ME, Pflugfelder SC. Inflammation in dry eye. Ocular Surf. 2004;2:124–130
  7. Fujishima H, Toda I, Shimazaki I, Tsubota K. Allergic conjunctivitis and dry eye. Br J Ophthalmol. 1996;80:994–997
  8. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25:900–907
  9. Baum J, Foulks G, Lemp MA. What's in a name?. Cornea. 2006;25:871–872
  10. American Academy of Ophthalmology. Dry Eye syndrome-Preferred practice patterns. American Academy of Ophthalmology; 2003;
  11. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318–326
  12. Toda I, Asano-Kato N, Komai-Hori Y, Tsubota K. Dry eye after laser in situ keratomileusis. Am J Ophthalmol. 2001;132:1–7
  13. Wilson SE. Laser in situ keratomileusis-induced (presumed) neurotrophic epitheliopathy. Ophthalmology. 2001;108:1082–1087
  14. De Paiva CS, Chen Z, Koch DD, et al. The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol. 2006;141:438–445
  15. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615–621
  16. Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409–415
  17. Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patient with dry eye disease. Ophthalmology. 2003;110:1412–1419
  18. Evans DJ, McNamara NA, Fleiszig SMJ. Life at the front: dissecting bacterial-host interactions at the ocular surface. Ocular Surf. 2007;5:213–227
  19. Beuerman RW, Stern ME. Neurogenic inflammation: a first line of defense for the ocular surface. Ocular Surf. 2005;3:S203–S206
  20. Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol. 2003;87:834–838
  21. Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea. 2008;27:22–27
  22. Foulks GN. Challenges and pitfalls in clinical trials of treatments for dry eye. Ocular Surf. 2003;1:20–30
  23. Tutt R, Bradley A, Begley C, Thibos LN. Optical and visual impact of tear break-up in human eyes. Invest Ophthalmol Vis Sci. 2000;41:4117–4123
  24. Ishida R, Kojima T, Dogru M, et al. The application of a new continuous functional visual acuity measurement system in dry eye syndromes. Am J Ophthalmol. 2005;139:253–258
  25. Yazdani C, Mclaughlin T, Smeeding JE, Walt J. Prevalence of treated dry eye disease in a managed care population. ClinTher. 2001;23:1672–1682
  26. Schein OD, Tielsch JM, Munoz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly (A population-based perspective). Ophthalmology. 1997;104:1395–1401
  27. Belmonte C, Aracil A, Acosta MC, Luna C, Gallar J. Nerves and sensations from the eye surface. Ocular Surf. 2004;2:248–253
  28. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762–770
  29. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr. 2005;82:887–893
  30. Hyon JY, Lee YJ, Yun PY. Management of ocular surface inflammation in Sjogren syndrome. Cornea. 2007;26:S13–S15
  31. De Paiva CS, Corrales RM, Villreal AL, et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res. 2006;83:526–535
  32. Ousler GW, Gomes PJ, Welch D, Abelson MB. Methodologies for the study of ocular surface disease. Ocular Surf. 2005;3:143–154
  33. Adatia FA, Michaeli-Cohen A, Naor J, Caffery B, Bookman A, Slomovic A. Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjogren's syndrome. Can J Ophthalmol. 2004;39:767–771

PII: S0002-9394(08)00386-3

doi: 10.1016/j.ajo.2008.05.016

American Journal of Ophthalmology
Volume 146, Issue 3 , Pages 350-356.e1 , September 2008

Article Tools